Gastroenterology and Hepatology from Bed to Bench

Abbaszadeh, H.-A., et al. (2017). "Er: YAG laser and cyclosporin A effect on cell cycle regulation of human gingival fibroblast cells." Journal of Lasers in Medical Sciences 8(3): 143-149.

Andersen, D. K., et al. (2017). "Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer." Diabetes 66(5): 1103-1110.

Bai, L., et al. (2015). "ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins." Medical oncology 32(3): 57.

Biernat, W., et al. (1995). "Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells." Journal of Neuropathology & Experimental Neurology 54(5): 651-656.

Bloomston, M., et al. (2007). "MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis." Jama 297(17): 1901-1908.

Chaiyadet, S., et al. (2017). "Proteomic characterization of the internalization of Opisthorchis viverrini excretory/secretory products in human cells." Parasitology international 66(4): 494-502.

Chera, S., et al. (2014). "Diabetes recovery by age-dependent conversion of pancreatic [dgr]-cells into insulin producers." Nature 514(7523): 503-507.

Cowgill, S. M. and P. Muscarella (2003). "The genetics of pancreatic cancer." The American journal of surgery 186(3): 279-286.

Esteller, M., et al. (2001). "A gene hypermethylation profile of human cancer." Cancer research 61(8): 3225-3229.

Falconer, J. S., et al. (1994). "Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer." Annals of surgery 219(4): 325.

Furukawa, T., et al. (2006). "AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer." Oncogene 25(35): 4831-4839.

Haruki, K., et al. (2016). "The C-reactive protein to albumin ratio predicts long-term outcomes in patients with pancreatic cancer after pancreatic resection." World journal of surgery 40(9): 2254-2260.

Karbalaei, R., et al. (2017). "One systems biology analysis protein-protein interaction of NASH and IBD based on comprehensive gene information." Gastroenterology and Hepatology from bed to bench: 194-201.

Khayyer, N., et al. (2017). "Oral Squamous Cell Cancer protein-protein interaction network interpretation in comparison to esophagus adenocarcinoma." Gastroenterology and Hepatology from bed to bench.

Li, Z., et al. (2017). "The OncoPPi network of cancer-focused protein–protein interactions to inform biological insights and therapeutic strategies." Nature communications 8: 14356.

Liu, R., et al. (2012). "Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer." Clinical chemistry 58(3): 610-618.

Ma, J., et al. (2010). "IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells." Journal of Surgical Research 160(1): 90-101.

Madhavan, B., et al. (2015). "Combined evaluation of a panel of protein and miRNA serum‐exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity." International journal of cancer 136(11): 2616-2627.

Maghvan, P. V., et al. (2017). "Network analysis of common genes related to esophageal, gastric, and colon cancers." Gastroenterology and Hepatology from bed to bench.

Mahlamäki, E. H., et al. (2002). "Frequent amplification of 8q24, 11q, 17q, and 20q‐specific genes in pancreatic cancer." Genes, chromosomes and cancer 35(4): 353-358.

Messersmith, W. A., et al. (2009). "Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts." Molecular cancer therapeutics 8(6): 1484-1493.

Paez, J. G., et al. (2004). "EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy." Science 304(5676): 1497-1500.

Payne, S., et al. (2015). "PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors." Oncogenesis 4(10): e169.

Peyvandi, A. A., et al. (2017). "Interactome Analysis of 11-Dehydrosinulariolide-Treated Oral Carcinoma Cell Lines Such as Ca9-22 and CAL-27 and Melanoma Cell Line." International Journal of Cancer Management(In Press).

Reis, R. M., et al. (2000). "Genetic profile of gliosarcomas." The American journal of pathology 156(2): 425-432.

Rezaei-Tavirani, M., et al. (2017). "Duchenne muscular dystrophy (DMD) protein-protein interaction mapping." Iranian Journal of Child Neurology 11(4): 7-14.

Rezaei-Tavirani, M., et al. (2017). "Introducing crucial protein panel of gastric adenocarcinoma disease." Gastroenterology and Hepatology from bed to bench 10(1): 21.

Safaei, A., et al. (2017). "Serum Metabolic Profiling of Advanced Cirrhosis Based on HCV." Hepatitis Monthly 17(3).

Safaei, A., et al. (2017). "Diabetic Retinopathy and Laser Therapy in Rats: A Protein-Protein Interaction Network Analysis." Journal of Lasers in Medical Sciences 8(Suppl 1): S20.

Safari-Alighiarloo, N., et al. (2016). "Network-based analysis of differentially expressed genes in cerebrospinal fluid (CSF) and blood reveals new candidate genes for multiple sclerosis." PeerJ 4: e2775.

Safari‐Alighiarloo, N., et al. (2017). "Identification of new key genes for type 1 diabetes through construction and analysis of protein–protein interaction networks based on blood and pancreatic islet transcriptomes." Journal of diabetes 9(8): 764-777.

Skrypek, N., et al. (2015). "The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2." Oncotarget 6(13): 10853.

Szklarczyk, D., et al. (2017). "The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible." Nucleic acids research 45(D1): D362-D368.

Tessari, G., et al. (1999). "The expression of proto-oncogene c-jun in human pancreatic cancer." Anticancer research 19(1B): 863-867.

Wang, Z., et al. (2006). "Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells." Molecular cancer therapeutics 5(3): 483-493.

Wu, Y., et al. (2016). Dexamethasone suppresses cytokine-induced dual oxidase 2 (Duox2) and VEGF-A expression in human pancreatic cancer cells in vitro and pancreatic cancer growth in xenografts, AACR.

Yadav, D. and A. B. Lowenfels (2013). "The epidemiology of pancreatitis and pancreatic cancer." Gastroenterology 144(6): 1252-1261.

Yun, J., et al. (2015). "Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH." Science 350(6266): 1391-1396.

Zamanian-azodi, M. and V. Mansouri (2017). "Exploring conserved mRNA-miRNA interactions in colon and lung cancers." Gastroenterology and Hepatology from bed to bench: 184-193.

Zhang, Y., et al. (2013). "PTEN/PI3K/mTOR/B7-H1 signaling pathway regulates cell progression and immuno-resistance in pancreatic cancer." Hepato-gastroenterology 60(127): 1766-1772.